Gelomics has won the 2024 KPMG Australia Tech Innovator challenge. The MedTech start-up, whose innovations allow pharma companies to grow human tissue in a petri dish, is now eyeing off the international title.
The KPMG Global Tech Innovator challenge seeks to recognise the most exciting and innovative tech startups globally. The Australian leg of the comp saw five finalist startups going head-to-head in a pitch off challenge, with Gelomics taking the top spot. Gelomic’s competitors were DoveTail Electric, Eden Brew, Sustainable Salons, and InTruth Technologies.
“All of our finalists came to the table with bold, industry-changing ideas,” said Amanda Price, Head of KPMG High Growth Ventures. “Each entry was unique and demonstrated a high level of global potential, making the selection process incredibly challenging.”
Now, Gelomics’ CEO and co-founder Christoph Meinert will present the startup’s ideas in front of 70,000 investors, policy makers, and industry leaders at Lisbon’s Web Summit. The Web Summit will also decide the global winner of the competition.
